Michael Barbella, Managing Editor04.20.24
New products proved to be pageview potentates this past week on the ODT website.
3D Systems led the way with news the FDA awarded 510(k) clearance to its 3D-printed, patient-specific cranial implant solution—VSP PEEK Cranial Implant— and its workflow. The VSP PEEK Cranial Implant reportedly is the first FDA-cleared additively manufactured PEEK implant intended for cranioplasty procedures to restore skull defects. PEEK has excellent biocompatibility, resistance to bodily fluids, and stability in a wide range of temperatures, making it an ideal choice for many medical device applications.
FDA approval also turned Xstim into a significant traffic driver: The company gained premarket approval from the agency for its Xstim spine fusion stimulator. The capacitively coupled device emits a low-energy signal to promote bone healing following spinal fusion surgery. The product streamlines patient therapy management with an intuitive interface and sleek design, which features a large onboard color display. Xstim is expected to release the device sometime this quarter.
Osso VR enticed a considerable number of cybervisitors as well with the launch of Osso Health, its medical training app on Apple Vision Pro. Osso Health's simulated surgical environment for Apple Vision Pro represents a major milestone in democratizing access to procedural education, according to Osso VR. With this launch, the company is extending its technology to a broader audience, making procedural education accessible to healthcare professionals, patients preparing for surgery, and individuals interested in medical innovation. The Osso Health app is designed to simulate medical procedures and seamlessly integrate the operating room into physical spaces while providing on-demand access to hands-on learning from anywhere.
Popular non-product news this week came from Orthofix, which hired a Stryker Corp. executive as chief legal officer.
3D Systems led the way with news the FDA awarded 510(k) clearance to its 3D-printed, patient-specific cranial implant solution—VSP PEEK Cranial Implant— and its workflow. The VSP PEEK Cranial Implant reportedly is the first FDA-cleared additively manufactured PEEK implant intended for cranioplasty procedures to restore skull defects. PEEK has excellent biocompatibility, resistance to bodily fluids, and stability in a wide range of temperatures, making it an ideal choice for many medical device applications.
FDA approval also turned Xstim into a significant traffic driver: The company gained premarket approval from the agency for its Xstim spine fusion stimulator. The capacitively coupled device emits a low-energy signal to promote bone healing following spinal fusion surgery. The product streamlines patient therapy management with an intuitive interface and sleek design, which features a large onboard color display. Xstim is expected to release the device sometime this quarter.
Osso VR enticed a considerable number of cybervisitors as well with the launch of Osso Health, its medical training app on Apple Vision Pro. Osso Health's simulated surgical environment for Apple Vision Pro represents a major milestone in democratizing access to procedural education, according to Osso VR. With this launch, the company is extending its technology to a broader audience, making procedural education accessible to healthcare professionals, patients preparing for surgery, and individuals interested in medical innovation. The Osso Health app is designed to simulate medical procedures and seamlessly integrate the operating room into physical spaces while providing on-demand access to hands-on learning from anywhere.
Popular non-product news this week came from Orthofix, which hired a Stryker Corp. executive as chief legal officer.